Tae Choi - BoryungPharm President Co-CEO, Director

003850 -- South Korea Stock  

KRW 15,750  400.00  2.61%

Choi Tae Hong was President CoChief Executive Officer and Director of Boryung Pharmaceutical Co. Ltd since March 18 2013. Choi was President of Janssen Korea Ltd. Choi holds a Master degree in Medicine from Seoul National University Korea.
Age: 55  CEO Since 2013      
82 2 708 8000  http://www.boryung.co.kr

Management Efficiency

The company has return on total asset (ROA) of 4.55 % which means that it generated profit of $4.55 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 11.5 % meaning that it generated $11.5 on every $100 dollars invested by stockholders.
The company has accumulated 100.15 B in total debt with debt to equity ratio (D/E) of 36.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. BoryungPharm has Current Ratio of 1.67 which is within standard range for the sector.

Entity Summary

Boryung Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products in South Korea. Boryung Pharmaceutical Co., Ltd. was founded in 1963 and is based in Seoul, South Korea. BoryungPharm is traded on Korea Stock Exchange in South Korea.BoryungPharm (003850) is traded on Korea Stock Exchange in South Korea and employs 1,005 people.

BoryungPharm Leadership Team

Haeng Jin, Non-Executive Independent Director
Han Lee, Managing Director
Gwang Gil, Non-Executive Independent Director
Jae Ahn, Co-Chief Executive Officer, Director
Yong Jeon, Managing Director
Yeong Kim, Managing Director
Je Kim, Assistant Managing Director
Sam Lee, Co-Chief Executive Officer, Director
Yong Kim, Assistant Managing Director
Ji Kim, Assistant Managing Director
Seung Kim, Chairman
Tae Choi, President Co-CEO, Director
Eun Kim, Chairman of the Board, Co-CEO

Stock Performance Indicators

Current Sentiment - 003850

BoryungPharm Investor Sentiment

Macroaxis portfolio users are unresponsive in their sentiment towards investing in BoryungPharm. What is your opinion about investing in BoryungPharm? Are you bullish or bearish?
50% Bullish
50% Bearish

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  
Check also Trending Equities. Please also try Equity Valuation module to check real value of public entities based on technical and fundamental data.
Search macroaxis.com